Physician

Eugene P Grady, M.D.

According to 2025 Medicare claims, Eugene Grady, M.D. (NPI: 1720015399) practices rheumatology in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Lackawanna, PA. This provider's primary affiliated billing organization is LEHIGH VALLEY PHYSICIAN GROUP (NPI: 1184799694; TIN: 232700908) and primary practice location at 18519-1668. Grady is affiliated with the Keystone ACO (ACO ID: A1552) and Lehigh Valley Health Network Accountable Care Organization, LLC (ACO ID: A2735), participating under the MSSP model.

Grady's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 978 traditional Medicare patients, billed 201,566 HCPCS/CPT codes, and received $2,177,610 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,431 prescription claims across 875 beneficiaries totaling $4,044,345 in drug costs, led by Enbrel Sureclick (Etanercept). DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,213,984 to $2,177,610. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,456,710 to $4,044,345. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,395 to $319.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	812	99,103	$1,213,984
2016	815	102,559	$1,442,077
2017	830	140,387	$1,611,225
2018	902	140,447	$1,811,139
2019	962	136,365	$2,011,926
2020	870	153,594	$2,229,819
2021	852	166,000	$2,346,597
2022	782	118,402	$1,335,619
2023	985	174,052	$2,025,337
2024	978	201,566	$2,177,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	653	6,611	$1,456,710
2016	696	6,843	$2,017,949
2017	739	7,249	$1,929,282
2018	779	7,394	$2,206,420
2019	779	6,944	$1,867,831
2020	774	7,245	$2,038,461
2021	769	7,274	$2,913,151
2022	802	7,654	$3,272,599
2023	845	7,663	$3,964,464
2024	875	7,431	$4,044,345

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	24	$1,920
2016	N/R	26	$2,212
2017	12	26	$950
2018	13	13	$651
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	22	$567
2023	N/R	12	$347
2024	N/R	11	$210

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	423	634	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	327	372	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	268	296	$12
96372	Injection of drug or substance under skin or into muscle	209	658	$10
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	180	1,588	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	106	3,052	$808,001
Rinvoq	Upadacitinib	105	3,690	$797,125
Humira(Cf) Pen	Adalimumab	73	2,044	$582,291
Xeljanz Xr	Tofacitinib Citrate	63	1,950	$363,190
Stelara	Ustekinumab	11	812	$210,243

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4595	Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)	N	N/R	11	$210

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Eugene P. Grady, M.D.?

Tedicare shows public-source Medicare data for Eugene P. Grady, M.D. (NPI 1720015399), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eugene P. Grady, M.D. have ACO affiliation data?

Eugene P. Grady, M.D. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and Lehigh Valley Health Network Accountable Care Organization, LLC (MSSP, ACO ID A2735).

What billing organization is linked to Eugene P. Grady, M.D.?

Eugene P. Grady, M.D. is linked to LEHIGH VALLEY PHYSICIAN GROUP (billing NPI 1184799694) in the available physician profile data.

Does Eugene P. Grady, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.